Frishman W, Smithen C, Kligfield P, Killip T
Cardiovasc Dis. 1974; 1(3):202-214.
PMID: 15215976
PMC: 287487.
Taylor S, Silke B, Nelson G, Okoli R, Ahuja R
Br Med J (Clin Res Ed). 1982; 285(6338):325-7.
PMID: 6807469
PMC: 1498994.
DOI: 10.1136/bmj.285.6338.325.
Chamberlain D, Vincent R
Drugs. 1984; 28 Suppl 2:88-108.
PMID: 6151893
DOI: 10.2165/00003495-198400282-00007.
Taylor S
Drugs. 1984; 28 Suppl 2:69-87.
PMID: 6151892
DOI: 10.2165/00003495-198400282-00006.
Giudicelli J, Chauvin M, Thuillez C, Richer C, Bianchetti G, Gomeni R
Br J Clin Pharmacol. 1980; 10(1):41-9.
PMID: 6104973
PMC: 1430023.
DOI: 10.1111/j.1365-2125.1980.tb00500.x.
Stimulation of adrenergic beta-receptors by orciprenaline.
Shanks R, Brick I, Hutchison K, Roddie I
Br Med J. 1967; 1(5540):610-2.
PMID: 6067167
PMC: 1841453.
DOI: 10.1136/bmj.1.5540.610.
Effect of propranolol on left atrial systole in ischaemic and hypertensive heart disease.
FLEMING J, Hamer J
Br Heart J. 1967; 29(2):257-63.
PMID: 6020821
PMC: 459141.
DOI: 10.1136/hrt.29.2.257.
Cardio-circulatory effects of beta-adrenergic blockade in organic heart disease. Comparison between propranolol and CIBA 39,089-Ba.
Grandjean T, RIVIER J
Br Heart J. 1968; 30(1):50-9.
PMID: 5637558
PMC: 459207.
DOI: 10.1136/hrt.30.1.50.
Effects of cedilanid-D and alprenolol in angina pectoris.
EKELUND L, Johnsson G, Melcher A, Oro L
Eur J Clin Pharmacol. 1973; 6(2):113-8.
PMID: 4769694
DOI: 10.1007/BF00562437.
Beta-adrenergic blocking agents and anaesthesia: a review.
WARNER W
Can Anaesth Soc J. 1968; 15(1):42-55.
PMID: 4157255
DOI: 10.1007/BF03005868.
Effects of single doses of alprenolol and two cardioselective beta-blockers (H 87-07 and H 93-26) on exercise-induced angina pectoris.
Adolfsson L, ARESKOG N, Furberg C, Johnsson G
Eur J Clin Pharmacol. 1974; 7(2):111-8.
PMID: 4152864
DOI: 10.1007/BF00561324.
Beta-adrenergic receptor blocking drugs in angina pectoris.
Prichard B
Drugs. 1974; 7(1):55-84.
PMID: 4151695
DOI: 10.2165/00003495-197407010-00005.
Celiprolol: a positive inotropic beta-adrenoceptor blocking agent in conscious dogs.
Nganele D, DeLeonardis V, Hintze T
Br J Pharmacol. 1988; 93(3):501-8.
PMID: 2897217
PMC: 1853856.
DOI: 10.1111/j.1476-5381.1988.tb10304.x.
Cardiac and renovascular effects in the anaesthetized dog of BW A575C: a novel angiotensin converting enzyme inhibitor with beta-adrenoceptor blocking properties.
Cambridge D, Whiting M, Allan G
Br J Pharmacol. 1988; 93(1):165-75.
PMID: 2894874
PMC: 1853785.
DOI: 10.1111/j.1476-5381.1988.tb11418.x.
The medical treatment of angina pectoris.
Chamberlain D
Br Heart J. 1987; 58(6):547-51.
PMID: 2892516
PMC: 1277332.
DOI: 10.1136/hrt.58.6.547.
Effects of atropine on left ventricular volumes and ejection and filling rates at rest and during exercise.
Kelbaek H, Marving J, Nielsen S
Br J Clin Pharmacol. 1991; 32(5):585-9.
PMID: 1954074
PMC: 1368635.
DOI: 10.1111/j.1365-2125.1991.tb03956.x.
Beta receptor antagonists in the treatment of heart failure.
Persson H, Erhardt L
Cardiovasc Drugs Ther. 1991; 5(3):589-604.
PMID: 1678962
DOI: 10.1007/BF03029728.
[Coronary heart disease and bypass surgery: a clinical cardiologist's view (author's transl)].
Lichtlen P
Langenbecks Arch Chir. 1975; 339:539-50.
PMID: 1082063
DOI: 10.1007/BF01257558.
Exercise tolerance in patients with angina pectoris after pentaerythritol trinitrate and alprenolol studied by two different methods.
EKELUND L, Melcher A, Oro L
Eur J Clin Pharmacol. 1975; 8(5):309-15.
PMID: 786682
DOI: 10.1007/BF00562655.
Effects of selective and non-selective beta-adrenergic blockade on coronary dynamics in man assessed by rapid atrial pacing.
Stephens J, Hayward R, Ead H, Adams L, Hamer J, Spurrell R
Br Heart J. 1978; 40(8):856-63.
PMID: 687486
PMC: 483499.
DOI: 10.1136/hrt.40.8.856.
